Sign up Australia
Proactive Investors - Run By Investors For Investors

Cellmid's Maria Halasz discussed growing revenue streams at Proactive's CEO Sessions

Maria Halasz discussed rapidly growing hair care sales at Proactive's CEO Sessions.
Cellmid's Maria Halasz with investors at Proactive's CEO Sessions
Maria Halasz, chief executive, presenting at Proactive's CEO Sessions

Cellmid's (ASX:CDY) chief executive, Maria Halasz, joined Proactive's CEO Sessions in Sydney on Tuesday 3rd October and Melbourne on Tuesday 4th October.

The company is growing revenues from sales of its hair care products in the U.S.

50% discount on all evolis products. The code Proinvestovs50 will be valid until 13th October 2017.

To claim the discount, put the code in at checkout and the payment amount will automatically be adjusted to 50%.

Please note this code will work on the www.evolisprofessional.com.au and www.evolisproducts.com.au websites for 1 week only.

ACCESS THE FULL PRESENTATION HERE


 

View full CDY profile View Profile

Cellmid Ltd Timeline

Related Articles

scientist in lab
September 07 2018
Normally, patients have to wait until regulators have approved a drug before they get access to it, but up to 500 lupus sufferers will receive Lupuzor as part of a Managed Access Programme
Zelda's Stewart Washer at Proactive's CEO Sessions
November 17 2017
Stewart Washer at Proactive's CEO Sessions this week.
scientist in lab
September 11 2018
The phase 1b trial of Silence’s lead candidate, SLN124, a treatment for a rare blood disorder, is scheduled to begin in the second half of 2019

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use